
1. j infect. 2010 apr;60(4):257-63. doi: 10.1016/j.jinf.2010.01.009. epub 2010 feb
4.

2009 h1n1 influenza infection cancer patients hematopoietic stem cell
transplant recipients.

redelman-sidi g(1), sepkowitz ka, huang ck, park s, stiles j, eagan j, perlin ds,
pamer eg, kamboj m.

author information: 
(1)memorial sloan-kettering cancer center, new york, ny 10065, usa.
redelmansidi@hotmail.com

comment in
    j infect. 2010 sep;61(3):270-2.
    j infect. 2010 nov;61(5):437-40.
    j infect. 2012 jul;65(1):88-90.

objectives: although usually mild, 2009 h1n1 influenza caused 6000
deaths us. determine outcome patients cancer and/or
hematopoietic stem cell transplant (hsct), reviewed recent experience at
memorial sloan-kettering cancer center (mskcc).
methods: initial nyc outbreak (may 19-june 30, 2009), respiratory 
samples mskcc tested 2009 h1n1 influenza dfa, culture, rt-pcr.
medical records reviewed cases.
results: 6-week period, 45(11%) 394 tested patients diagnosed 
with 2009 h1n1 influenza. included 29(17%) 167 patients hematologic
conditions compared 16(7%) 226 solid tumors (p < 0.01). 21(22%) 96 
tested hsct recipients positive. cough (93%) fever (91%) common. of
29 patients radiographically assessed, 8(27%) lower airway disease. 
17(37%) hospitalized. none required mechanical ventilation. deaths were
attributed influenza. treated patients tolerated antiviral medication.
conclusions: 2009 h1n1 influenza caused mild symptoms patients with
cancer and/or hsct. none died required mechanical ventilation.
immunosuppression cancer treatment including hsct may a
substantial risk poor outcome, however studies needed validate
our results.

copyright 2010 british infection society. published elsevier ltd. all
rights reserved.

doi: 10.1016/j.jinf.2010.01.009 
pmid: 20138188  [indexed medline]

